Targeting ERBB2 Mutations in Solid Tumors: Biological and Clinical Implications

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-018-0630-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting Trop-2 in Solid Tumors: Future Prospects

OncoTargets and Therapy
OncologyPharmacology
2019English

Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

Clinical and Biological Implications of the Tumor Microenvironment

Cancer Microenvironment
Cancer ResearchOncology
2012English

Clinical Implications of CTNNA1 Germline Mutations in Asymptomatic Carriers

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2018English

Comparisons of Metastases in Different Organs: Biological and Clinical Implications

Clinical Cancer Research
Cancer ResearchOncology
2008English

Clinical Implications of Germline Mutations in Breast Cancer Genes: RECQL

Breast Cancer Research and Treatment
Cancer ResearchOncology
2019English

Detection of Low Prevalence Somatic Mutations in Solid Tumors With Ultra-Deep Targeted Sequencing

Genome Biology
2011English

Solid Tumors

Bone Marrow Transplantation
TransplantationHematology
1999English

Braf and erbB2 Mutations Correlate With Smoking Status in Lung Cancer Patients

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy